Skip to main content
logo
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
446.40
-26.80 (-5.66%)
Oct 22, 2026, 2:55 PM HKT

HKG:6990 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,0862,0581,9331,540803.9332.32
Revenue Growth
1.35%6.46%25.48%91.62%2387.26%-
Gross Profit
1,5561,4791,274759.19526.89.25
Operating Income
-4.15-419.57-279.22-453.7-393.95-795.24
Net Income
151.21-381.97-266.77-522.21-548.1-822.55
Earnings Per Share
0.65-1.66-1.20-2.84-5.74-8.90
EPS Growth
------

Revenue by Geography
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
The PRC
912.59571.292.657.5456.4920.39
The United States of America
1,1211,3151,8401,528730.04-
Switzerland
48.76168.69----
Other Countries
-3.31-4.7317.4111.94
Total
2,0862,0581,9331,540803.9332.32

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4,7784,4723,0692,48892.9681.79
Total Debt
81.3588.44126.7559.923,0142,391
Net Cash (Debt)
4,6964,3832,9422,428-2,921-2,309
Net Cash Growth
7.14%48.99%21.15%---
Net Cash Per Share
20.1319.0113.2713.22-30.58-24.98

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
531.69-180.3-429.7759.56-270.85-485.94
Capital Expenditures
-110.89-125.69-77.46-80.98-33.66-94.08
Free Cash Flow
420.8-305.99-507.23-21.42-304.51-580.03
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
74.59%71.86%65.89%49.28%65.53%28.62%
Operating Margin
-0.20%-20.39%-14.45%-29.45%-49.00%-2460.37%
Pretax Margin
3.25%-17.29%-7.37%-30.36%-70.57%-2752.91%
Profit Margin
7.25%-18.56%-13.80%-33.90%-68.18%-2544.86%
FCF Margin
20.17%-14.87%-26.24%-1.39%-37.88%-1794.52%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
46.9739.9418.0413.29--